Fatal Pediatric COVID-19 Case With Seizures and Fulminant Cerebral Edema

Siddharth Ninan1, Peyton Thompson2, Timothy Gershon2

  • 1Department of Neurology, University of North Carolina at Chapel Hill, NC, USA.

Child Neurology Open
|June 28, 2021
PubMed

Insights

COVID-19 can trigger acute fulminant cerebral edema (AFCE) in children, a severe neurological condition. Early recognition of this rare complication is crucial for prompt medical intervention and improved outcomes.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Pediatrics

Background:

  • The novel coronavirus, SARS-CoV-2, is known to cause diverse neurological symptoms in adults and children.
  • Acute fulminant cerebral edema (AFCE) is a rare, often fatal, pediatric condition characterized by fever, encephalopathy, seizures, and refractory cerebral edema.

Observation:

  • A previously healthy 8-year-old girl developed seizures, encephalopathy, and fatal cerebral edema during acute COVID-19 infection.
  • Cerebrospinal fluid analysis, microbiological tests, and neuropathology ruled out direct central nervous system infection or inflammation.

Findings:

  • COVID-19 infection can precipitate AFCE in pediatric patients.
  • The pathophysiology of AFCE in this context appears to be para-infectious, rather than a direct CNS infection.

Implications:

  • This case highlights the importance of considering COVID-19 as a potential trigger for AFCE in children.
  • High clinical suspicion and early diagnosis of AFCE in the setting of COVID-19 are critical for timely management.